Chiesi has taken the lead in making an upfront investment in a new platform of inhalers, called the carbon minimal inhalers, ...

The Medtech sector is at a critical moment, where innovation and regulation must coexist. A stricter regulatory environment ...

The antibody-drug conjugate (ADC) is currently under review by the FDA as a treatment for advanced or metastatic non-squamous ...

MSD's PD-1 inhibitor Keytruda has ruled the immunotherapy of non-small cell lung cancer (NSCLC) for many years, but a ...

In final draft guidance due to be finalised before the end of the month, Welireg (belzutifan) has been recommended as an ...

MSD and Daiichi Sankyo started enrolling patients into the phase 3 Ideate-Lung02 study in the summer.

The Missouri case was detected through routine flu season surveillance, said the CDC, and is also the first time that an H5 ...

AstraZeneca has confirmed that some of its current and former employees have been taken into custody in China as part of an ...

The agreement ties in with Lilly's strategy of making genetic medicines targeting DNA and RNA a key pillar of its R&D, ...

The headline result from the MATINEE trial of IL-5 inhibitor Nucala (mepolizumab) in adults with COPD was a statistically ...

Medscape Medical Affairs operates across every phase of the medical discovery and development process, ensuring that the ...

Now, in a stunning reversal, Advanz has won a reprieve after the General Court of the European Union ordered a suspension of ...